The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.
The global Contraceptives market size is expected to reach US$ 2277.4 million by 2029, growing at a CAGR of 2.5% from 2023 to 2029. The market is mainly driven by the significant applications of Contraceptives in various end use industries. The expanding demands from the 15–24 years, 25–34 years, 35–44 years and Above 44 years, are propelling Contraceptives market. Pills, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injectable segment is estimated at % CAGR for the next seven-year period.
Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share.
The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine etc. Top 3 companies occupied about 46% market share.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by End User. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Contraceptives, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Contraceptives market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Contraceptives market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Contraceptives sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Contraceptives covered in this report include Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S and ZiZhu, etc.
The global Contraceptives market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
- Bayer AG
- Pfizer, Inc
- Teva Pharmaceutical Industries Ltd
- Merck & Co., Inc
- Actavis, Inc.
- Johnson & Johnson
- Gedeon Richter
- Novo Nordisk A/S
- ZiZhu
- Baijingyu
- Huazhong
- Sine
- Reckitt
- AbbVie
- Church & Dwight
- The Cooper Companies
- TherapeuticsMD
- Afaxys
- Mithra Pharmaceuticals
Global Contraceptives market, by region:
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, etc.)
- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
- South America (Brazil, etc.)
- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Contraceptives market, Segment by Type:
- Pills
- Injectable
- Condoms
- Vaginal Rings
- IUDs
- Subdermal Implants
- Others
Global Contraceptives market, by End User
- 15–24 years
- 25–34 years
- 35–44 years
- Above 44 years
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Contraceptives manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Contraceptives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by End User, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Contraceptives Market Overview
1.1 Contraceptives Product Overview
1.2 Contraceptives Market Segment by Type
1.2.1 Pills
1.2.2 Injectable
1.2.3 Condoms
1.2.4 Vaginal Rings
1.2.5 IUDs
1.2.6 Subdermal Implants
1.2.7 Others
1.3 Global Contraceptives Market Size by Type
1.3.1 Global Contraceptives Market Size Overview by Type (2018-2029)
1.3.2 Global Contraceptives Historic Market Size Review by Type (2018-2023)
1.3.3 Global Contraceptives Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Contraceptives Sales Breakdown by Type (2018-2023)
1.4.2 Europe Contraceptives Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Contraceptives Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Contraceptives Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Contraceptives Sales Breakdown by Type (2018-2023)
2 Global Contraceptives Market Competition by Company
2.1 Global Top Players by Contraceptives Sales (2018-2023)
2.2 Global Top Players by Contraceptives Revenue (2018-2023)
2.3 Global Top Players by Contraceptives Price (2018-2023)
2.4 Global Top Manufacturers Contraceptives Manufacturing Base Distribution, Sales Area, Product Type
2.5 Contraceptives Market Competitive Situation and Trends
2.5.1 Contraceptives Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Contraceptives Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Contraceptives as of 2022)
2.7 Date of Key Manufacturers Enter into Contraceptives Market
2.8 Key Manufacturers Contraceptives Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Contraceptives Status and Outlook by Region
3.1 Global Contraceptives Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Contraceptives Historic Market Size by Region
3.2.1 Global Contraceptives Sales in Volume by Region (2018-2023)
3.2.2 Global Contraceptives Sales in Value by Region (2018-2023)
3.2.3 Global Contraceptives Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Contraceptives Forecasted Market Size by Region
3.3.1 Global Contraceptives Sales in Volume by Region (2024-2029)
3.3.2 Global Contraceptives Sales in Value by Region (2024-2029)
3.3.3 Global Contraceptives Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Contraceptives by End User
4.1 Contraceptives Market Segment by End User
4.1.1 15–24 years
4.1.2 25–34 years
4.1.3 35–44 years
4.1.4 Above 44 years
4.2 Global Contraceptives Market Size by End User
4.2.1 Global Contraceptives Market Size Overview by End User (2018-2029)
4.2.2 Global Contraceptives Historic Market Size Review by End User (2018-2023)
4.2.3 Global Contraceptives Forecasted Market Size by End User (2024-2029)
4.3 Key Regions Market Size Segment by End User
4.3.1 North America Contraceptives Sales Breakdown by End User (2018-2023)
4.3.2 Europe Contraceptives Sales Breakdown by End User (2018-2023)
4.3.3 Asia-Pacific Contraceptives Sales Breakdown by End User (2018-2023)
4.3.4 Latin America Contraceptives Sales Breakdown by End User (2018-2023)
4.3.5 Middle East and Africa Contraceptives Sales Breakdown by End User (2018-2023)
5 North America Contraceptives by Country
5.1 North America Contraceptives Historic Market Size by Country
5.1.1 North America Contraceptives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Contraceptives Sales in Volume by Country (2018-2023)
5.1.3 North America Contraceptives Sales in Value by Country (2018-2023)
5.2 North America Contraceptives Forecasted Market Size by Country
5.2.1 North America Contraceptives Sales in Volume by Country (2024-2029)
5.2.2 North America Contraceptives Sales in Value by Country (2024-2029)
6 Europe Contraceptives by Country
6.1 Europe Contraceptives Historic Market Size by Country
6.1.1 Europe Contraceptives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Contraceptives Sales in Volume by Country (2018-2023)
6.1.3 Europe Contraceptives Sales in Value by Country (2018-2023)
6.2 Europe Contraceptives Forecasted Market Size by Country
6.2.1 Europe Contraceptives Sales in Volume by Country (2024-2029)
6.2.2 Europe Contraceptives Sales in Value by Country (2024-2029)
7 Asia-Pacific Contraceptives by Region
7.1 Asia-Pacific Contraceptives Historic Market Size by Region
7.1.1 Asia-Pacific Contraceptives Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Contraceptives Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Contraceptives Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Contraceptives Forecasted Market Size by Region
7.2.1 Asia-Pacific Contraceptives Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Contraceptives Sales in Value by Region (2024-2029)
8 Latin America Contraceptives by Country
8.1 Latin America Contraceptives Historic Market Size by Country
8.1.1 Latin America Contraceptives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Contraceptives Sales in Volume by Country (2018-2023)
8.1.3 Latin America Contraceptives Sales in Value by Country (2018-2023)
8.2 Latin America Contraceptives Forecasted Market Size by Country
8.2.1 Latin America Contraceptives Sales in Volume by Country (2024-2029)
8.2.2 Latin America Contraceptives Sales in Value by Country (2024-2029)
9 Middle East and Africa Contraceptives by Country
9.1 Middle East and Africa Contraceptives Historic Market Size by Country
9.1.1 Middle East and Africa Contraceptives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Contraceptives Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Contraceptives Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Contraceptives Forecasted Market Size by Country
9.2.1 Middle East and Africa Contraceptives Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Contraceptives Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bayer AG
10.1.1 Bayer AG Company Information
10.1.2 Bayer AG Introduction and Business Overview
10.1.3 Bayer AG Contraceptives Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bayer AG Contraceptives Products Offered
10.1.5 Bayer AG Recent Development
10.2 Pfizer, Inc
10.2.1 Pfizer, Inc Company Information
10.2.2 Pfizer, Inc Introduction and Business Overview
10.2.3 Pfizer, Inc Contraceptives Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Pfizer, Inc Contraceptives Products Offered
10.2.5 Pfizer, Inc Recent Development
10.3 Teva Pharmaceutical Industries Ltd
10.3.1 Teva Pharmaceutical Industries Ltd Company Information
10.3.2 Teva Pharmaceutical Industries Ltd Introduction and Business Overview
10.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Teva Pharmaceutical Industries Ltd Contraceptives Products Offered
10.3.5 Teva Pharmaceutical Industries Ltd Recent Development
10.4 Merck & Co., Inc
10.4.1 Merck & Co., Inc Company Information
10.4.2 Merck & Co., Inc Introduction and Business Overview
10.4.3 Merck & Co., Inc Contraceptives Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Merck & Co., Inc Contraceptives Products Offered
10.4.5 Merck & Co., Inc Recent Development
10.5 Actavis, Inc.
10.5.1 Actavis, Inc. Company Information
10.5.2 Actavis, Inc. Introduction and Business Overview
10.5.3 Actavis, Inc. Contraceptives Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Actavis, Inc. Contraceptives Products Offered
10.5.5 Actavis, Inc. Recent Development
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Company Information
10.6.2 Johnson & Johnson Introduction and Business Overview
10.6.3 Johnson & Johnson Contraceptives Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Johnson & Johnson Contraceptives Products Offered
10.6.5 Johnson & Johnson Recent Development
10.7 Gedeon Richter
10.7.1 Gedeon Richter Company Information
10.7.2 Gedeon Richter Introduction and Business Overview
10.7.3 Gedeon Richter Contraceptives Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Gedeon Richter Contraceptives Products Offered
10.7.5 Gedeon Richter Recent Development
10.8 Novo Nordisk A/S
10.8.1 Novo Nordisk A/S Company Information
10.8.2 Novo Nordisk A/S Introduction and Business Overview
10.8.3 Novo Nordisk A/S Contraceptives Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Novo Nordisk A/S Contraceptives Products Offered
10.8.5 Novo Nordisk A/S Recent Development
10.9 ZiZhu
10.9.1 ZiZhu Company Information
10.9.2 ZiZhu Introduction and Business Overview
10.9.3 ZiZhu Contraceptives Sales, Revenue and Gross Margin (2018-2023)
10.9.4 ZiZhu Contraceptives Products Offered
10.9.5 ZiZhu Recent Development
10.10 Baijingyu
10.10.1 Baijingyu Company Information
10.10.2 Baijingyu Introduction and Business Overview
10.10.3 Baijingyu Contraceptives Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Baijingyu Contraceptives Products Offered
10.10.5 Baijingyu Recent Development
10.11 Huazhong
10.11.1 Huazhong Company Information
10.11.2 Huazhong Introduction and Business Overview
10.11.3 Huazhong Contraceptives Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Huazhong Contraceptives Products Offered
10.11.5 Huazhong Recent Development
10.12 Sine
10.12.1 Sine Company Information
10.12.2 Sine Introduction and Business Overview
10.12.3 Sine Contraceptives Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Sine Contraceptives Products Offered
10.12.5 Sine Recent Development
10.13 Reckitt
10.13.1 Reckitt Company Information
10.13.2 Reckitt Introduction and Business Overview
10.13.3 Reckitt Contraceptives Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Reckitt Contraceptives Products Offered
10.13.5 Reckitt Recent Development
10.14 AbbVie
10.14.1 AbbVie Company Information
10.14.2 AbbVie Introduction and Business Overview
10.14.3 AbbVie Contraceptives Sales, Revenue and Gross Margin (2018-2023)
10.14.4 AbbVie Contraceptives Products Offered
10.14.5 AbbVie Recent Development
10.15 Church & Dwight
10.15.1 Church & Dwight Company Information
10.15.2 Church & Dwight Introduction and Business Overview
10.15.3 Church & Dwight Contraceptives Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Church & Dwight Contraceptives Products Offered
10.15.5 Church & Dwight Recent Development
10.16 The Cooper Companies
10.16.1 The Cooper Companies Company Information
10.16.2 The Cooper Companies Introduction and Business Overview
10.16.3 The Cooper Companies Contraceptives Sales, Revenue and Gross Margin (2018-2023)
10.16.4 The Cooper Companies Contraceptives Products Offered
10.16.5 The Cooper Companies Recent Development
10.17 TherapeuticsMD
10.17.1 TherapeuticsMD Company Information
10.17.2 TherapeuticsMD Introduction and Business Overview
10.17.3 TherapeuticsMD Contraceptives Sales, Revenue and Gross Margin (2018-2023)
10.17.4 TherapeuticsMD Contraceptives Products Offered
10.17.5 TherapeuticsMD Recent Development
10.18 Afaxys
10.18.1 Afaxys Company Information
10.18.2 Afaxys Introduction and Business Overview
10.18.3 Afaxys Contraceptives Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Afaxys Contraceptives Products Offered
10.18.5 Afaxys Recent Development
10.19 Mithra Pharmaceuticals
10.19.1 Mithra Pharmaceuticals Company Information
10.19.2 Mithra Pharmaceuticals Introduction and Business Overview
10.19.3 Mithra Pharmaceuticals Contraceptives Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Mithra Pharmaceuticals Contraceptives Products Offered
10.19.5 Mithra Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Contraceptives Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Contraceptives Industrial Chain Analysis
11.4 Contraceptives Market Dynamics
11.4.1 Contraceptives Industry Trends
11.4.2 Contraceptives Market Drivers
11.4.3 Contraceptives Market Challenges
11.4.4 Contraceptives Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Contraceptives Distributors
12.3 Contraceptives Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
